Publikationen, an denen er mitarbeitet CRISTINA SARASQUETA EIZAGUIRRE (11)

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  2. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

    Quality of Life Research, Vol. 32, Núm. 4, pp. 989-1003

2022

  1. Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)

    Scientific Reports

2021

  1. Factors that Influence Treatment Delay for Patients with Breast Cancer

    Annals of Surgical Oncology, Vol. 28, Núm. 7, pp. 3714-3721

2020

  1. Factors associated with colon cancer early, intermediate and late recurrence after surgery for stage I–III: A 5-year prospective study

    European Journal of Cancer Care, Vol. 29, Núm. 6

  2. Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer

    Surgical Endoscopy, Vol. 32, Núm. 12, pp. 4912-4922

  2. Outcomes of open versus laparoscopic surgery in patients with colon cancer

    European Journal of Surgical Oncology, Vol. 44, Núm. 9, pp. 1344-1353

  3. PR-LncRNA signature regulates glioma cell activity through expression of SOX factors

    Scientific Reports, Vol. 8, Núm. 1

2009

  1. Características clinicopatológicas y supervivencia de los pacientes con cáncer de esófago. Resultados de 200 casos consecutivos

    Medicina Clinica, Vol. 133, Núm. 18, pp. 689-693

  2. Supervivencia relativa en cáncer de mama después de la primera recidiva y factores pronóstico asociados

    Medicina Clinica, Vol. 133, Núm. 13, pp. 489-495